INTS1
Integrator complex subunit 1
Also known as: DKFZp586J0619, INT1, INT1_HUMAN, KIAA1440, NET28
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N201
- Gene
- INTS1
- Ensembl
- ENSG00000164880
- Chromosome
- 7
- Canonical length
- 2190 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
INTS1 is a subunit of the Integrator complex, which associates with the C-terminal domain of RNA polymerase II large subunit (POLR2A; MIM 180660) and mediates 3-prime end processing of small nuclear RNAs U1 (RNU1; MIM 180680) and U2 (RNU2; MIM 180690) (Baillat et al., 2005 [PubMed 16239144]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
2190 residues, UniProt reviewed canonical sequence.
>Q8N201|INTS1
1 MNRAKPTTVR RPSAAAKPSG HPPPGDFIAL GSKGQANESK TASTLLKPAP SGLPSERKRD
61 AAAALSSASA LTGLTKRPKL SSTPPLSALG RLAEAAVAEK RAISPSIKEP SVVPIEVLPT
121 VLLDEIEAAE LEGNDDRIEG VLCGAVKQLK VTRAKPDSTL YLSLMYLAKI KPNIFATEGV
181 IEALCSLLRR DASINFKAKG NSLVSVLACN LLMAAYEEDE NWPEIFVKVY IEDSLGERIW
241 VDSPHCKTFV DNIQTAFNTR MPPRSVLLQG EAGRVAGDLG AGSSPHPSLT EEEDSQTELL
301 IAEEKLSPEQ EGQLMPRYEE LAESVEEYVL DMLRDQLNRR QPIDNVSRNL LRLLTSTCGY
361 KEVRLLAVQK LEMWLQNPKL TRPAQDLLMS VCMNCNTHGS EDMDVISHLI KIRLKPKVLL
421 NHFMLCIREL LSAHKDNLGT TIKLVIFNEL SSARNPNNMQ VLYTALQHSS ELAPKFLAMV
481 FQDLLTNKDD YLRASRALLR EIIKQTKHEI NFQAFCLGLM QERKEPQYLE MEFKERFVVH
541 ITDVLAVSMM LGITAQVKEA GIAWDKGEKR NLEVLRSFQN QIAAIQRDAV WWLHTVVPSI
601 SKLAPKDYVH CLHKVLFTEQ PETYYKWDNW PPESDRNFFL RLCSEVPILE DTLMRILVIG
661 LSRELPLGPA DAMELADHLV KRAAAVQADD VEVLKVGRTQ LIDAVLNLCT YHHPENIQLP
721 PGYQPPNLAI STLYWKAWPL LLVVAAFNPE NIGLAAWEEY PTLKMLMEMV MTNNYSYPPC
781 TLTDEETRTE MLNRELQTAQ REKQEILAFE GHLAAASTKQ TITESSSLLL SQLTSLDPQG
841 PPRRPPPHIL DQVKSLNQSL RLGHLLCRSR NPDFLLHIIQ RQASSQSMPW LADLVQSSEG
901 SLDVLPVQCL CEFLLHDAVD DAASGEEDDE GESKEQKAKK RQRQQKQRQL LGRLQDLLLG
961 PKADEQTTCE VLDYFLRRLG SSQVASRVLA MKGLSLVLSE GSLRDGEEKE PPMEEDVGDT
1021 DVLQGYQWLL RDLPRLPLFD SVRSTTALAL QQAIHMETDP QTISAYLIYL SQHTPVEEQA
1081 QHSDLALDVA RLVVERSTIM SHLFSKLSPS AASDAVLSAL LSIFSRYVRR MRQSKEGEEV
1141 YSWSESQDQV FLRWSSGETA TMHILVVHAM VILLTLGPPR ADDSEFQALL DIWFPEEKPL
1201 PTAFLVDTSE EALLLPDWLK LRMIRSEVLR LVDAALQDLE PQQLLLFVQS FGIPVSSMSK
1261 LLQFLDQAVA HDPQTLEQNI MDKNYMAHLV EVQHERGASG GQTFHSLLTA SLPPRRDSTE
1321 APKPKSSPEQ PIGQGRIRVG TQLRVLGPED DLAGMFLQIF PLSPDPRWQS SSPRPVALAL
1381 QQALGQELAR VVQGSPEVPG ITVRVLQALA TLLSSPHGGA LVMSMHRSHF LACPLLRQLC
1441 QYQRCVPQDT GFSSLFLKVL LQMLQWLDSP GVEGGPLRAQ LRMLASQASA GRRLSDVRGG
1501 LLRLAEALAF RQDLEVVSST VRAVIATLRS GEQCSVEPDL ISKVLQGLIE VRSPHLEELL
1561 TAFFSATADA ASPFPACKPV VVVSSLLLQE EEPLAGGKPG ADGGSLEAVR LGPSSGLLVD
1621 WLEMLDPEVV SSCPDLQLRL LFSRRKGKGQ AQVPSFRPYL LTLFTHQSSW PTLHQCIRVL
1681 LGKSREQRFD PSASLDFLWA CIHVPRIWQG RDQRTPQKRR EELVLRVQGP ELISLVELIL
1741 AEAETRSQDG DTAACSLIQA RLPLLLSCCC GDDESVRKVT EHLSGCIQQW GDSVLGRRCR
1801 DLLLQLYLQR PELRVPVPEV LLHSEGAASS SVCKLDGLIH RFITLLADTS DSRALENRGA
1861 DASMACRKLA VAHPLLLLRH LPMIAALLHG RTHLNFQEFR QQNHLSCFLH VLGLLELLQP
1921 HVFRSEHQGA LWDCLLSFIR LLLNYRKSSR HLAAFINKFV QFIHKYITYN APAAISFLQK
1981 HADPLHDLSF DNSDLVMLKS LLAGLSLPSR DDRTDRGLDE EGEEESSAGS LPLVSVSLFT
2041 PLTAAEMAPY MKRLSRGQTV EDLLEVLSDI DEMSRRRPEI LSFFSTNLQR LMSSAEECCR
2101 NLAFSLALRS MQNSPSIAAA FLPTFMYCLG SQDFEVVQTA LRNLPEYALL CQEHAAVLLH
2161 RAFLVGMYGQ MDPSAQISEA LRILHMEAVMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against INTS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 53 nTPM
- testis: 45 nTPM
- cerebellum: 39 nTPM
- cerebral cortex: 32 nTPM
- pancreas: 30 nTPM
- ovary: 27 nTPM
Single-cell type
- late spermatids: 61 nCPM
- proximal tubule cells: 47 nCPM
- retinal horizontal cells: 46 nCPM
- neutrophil progenitors: 43 nCPM
- colonocytes: 40 nCPM
- brain excitatory neurons: 39 nCPM
Immune cell
- naive B-cell: 2.7 nTPM
- basophil: 2 nTPM
- gdT-cell: 1.5 nTPM
- T-reg: 1.5 nTPM
- memory CD8 T-cell: 1.2 nTPM
- myeloid DC: 1.2 nTPM
Brain region
- cerebral cortex: 70 nTPM
- medulla oblongata: 66 nTPM
- amygdala: 65 nTPM
- hippocampal formation: 64 nTPM
- thalamus: 59 nTPM
- white matter: 58 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about INTS1.
Disease | AllUniProt
Conditions INTS1 is implicated in, by any mechanism.
- Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies (NDCAGF) MIM:618571
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 806 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies
- Inborn genetic diseases
- Neurodevelopmental delay
- See cases
- Malignant tumor of esophagus
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- -0.86
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- embryo implantation
- inner cell mass cell proliferation
- negative regulation of apoptotic process
- regulation of transcription elongation by RNA polymerase II
- RNA polymerase II transcription initiation surveillance
- snRNA processing
- U2 snRNA 3'-end processing
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-type fold
- Integrator complex subunit 1, RPB2-binding domain
- Integrator complex subunit 1
- Integrator complex subunit 1, R3 domain
- Integrator complex subunit 1, R4 domain
- Integrator complex subunit 1, INTS2-binding domain
- Integrator complex subunit 1, RP2B-binding domain
- Integrator complex subunit 1, R3 domain
- Integrator complex subunit 1, R4 domain
- Integrator complex subunit 1, INTS2-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of INTS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads INTS1 as an antibody target. Whether an autoantibody or antibody against INTS1 could matter depends on whether native INTS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
INTS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label INTS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...